Success Metrics

Clinical Success Rate
93.9%

Based on 123 completed trials

Completion Rate
94%(123/131)
Active Trials
10(6%)
Results Posted
28%(35 trials)
Terminated
8(5%)

Phase Distribution

Ph not_applicable
29
19%
Ph phase_1
43
28%
Ph phase_4
16
10%
Ph phase_2
26
17%
Ph phase_3
36
23%

Phase Distribution

43

Early Stage

26

Mid Stage

52

Late Stage

Phase Distribution150 total trials
Phase 1Safety & dosage
43(28.7%)
Phase 2Efficacy & side effects
26(17.3%)
Phase 3Large-scale testing
36(24.0%)
Phase 4Post-market surveillance
16(10.7%)
N/ANon-phased studies
29(19.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.8%

123 of 134 finished

Non-Completion Rate

8.2%

11 ended early

Currently Active

10

trials recruiting

Total Trials

156

all time

Status Distribution
Active(11)
Completed(123)
Terminated(11)
Other(11)

Detailed Status

Completed123
unknown11
Recruiting10
Terminated8
Withdrawn3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
156
Active
10
Success Rate
93.9%
Most Advanced
Phase 4

Trials by Phase

Phase 143 (28.7%)
Phase 226 (17.3%)
Phase 336 (24.0%)
Phase 416 (10.7%)
N/A29 (19.3%)

Trials by Status

recruiting106%
not_yet_recruiting11%
terminated85%
unknown117%
completed12379%
withdrawn32%

Recent Activity

Clinical Trials (156)

Showing 20 of 156 trialsScroll for more
NCT04368559Phase 3

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

Completed
NCT07439250Phase 1

A Study of Olomorasib (LY3537982) in Healthy Participants

Recruiting
NCT05421858Phase 3

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.

Recruiting
NCT07395024Phase 1

A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adults

Recruiting
NCT07341672Phase 1

A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants

Not Yet Recruiting
NCT05178862Phase 3

A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole

Terminated
NCT03828773Not Applicable

PTX3-targeted Antifungal Prophylaxis

Recruiting
NCT06274554Phase 3

Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease

Recruiting
NCT02145832Phase 2

Fluconazole Versus Micafungin in Neonates With Candidiasis

Completed
NCT06847464Phase 1

A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.

Completed
NCT06345794Phase 1

A Study to Assess LY4100511 (DC-853) in Healthy Adult Participants

Completed
NCT06922344Phase 4

Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor

Recruiting
NCT06822166Phase 1

Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride

Completed
NCT03135106Phase 1

A Study to Evaluate the Effect of Fluconazole and Itraconazole on Erdafitinib Pharmacokinetics in Healthy Adult Participants

Completed
NCT06770530Phase 4

Introduction of Mycotic Prophylaxis At Cystectomy Trial.

Recruiting
NCT06709196Phase 4

Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis

Recruiting
NCT01058174Phase 3

Liver Transplant European Study Into the Prevention of Fungal Infection

Completed
NCT04551963Phase 1

Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies

Completed
NCT01503515Phase 3

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

Completed
NCT05076409Phase 1

A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood

Completed

Drug Details

Intervention Type
DRUG
Total Trials
156